RGNX — REGENXBIO INC

Ownership history in ALGERT GLOBAL LLC  ·  7 quarters on record

This page tracks every 13F SEC filing in which ALGERT GLOBAL LLC reported a position in REGENXBIO INC (RGNX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.39% (2020 Q4)
Avg. % of fund
0.09%
First filed
2020 Q3
Last filed
2025 Q3
Quarters held
7
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 10,040 -10,208 -50.4% 0.00% $97K $9.65
2025 Q2 REDUCED 20,248 -29,330 -59.2% 0.00% $166K $8.21
2025 Q1 ADDED 49,578 +31,588 +175.6% 0.01% $354K $7.15
2023 Q4 ADDED 17,990 +6,917 +62.5% 0.01% $323K $17.95
2022 Q1 REDUCED 11,073 -19,051 -63.2% 0.02% $368K $33.19
2020 Q4 ADDED 30,124 +11,343 +60.4% 0.39% $1.4M $45.36
2020 Q3 INITIATED 18,781 — — 0.16% $517K $27.52
% of Fund (quarterly)    RGNX price (monthly, adj. close)

Other funds also holding RGNX

As of 2025 Q4 — sorted by position size

22NW, LP 3Y 7Y 5.6% Redmile Group, LLC 3Y 7Y 4.63% Lion Point Capital, LP 3Y 7Y 1.98% Propel Bio Management, LLC 1.44% Integral Health Asset Management, LLC 3Y 0.86% ArchPoint Investors 3Y 7Y 0.76% GSK plc 0.49% Pale Fire Capital SE 3Y 0.48% Voss Capital, LP 3Y 0.2% ADAR1 Capital Management, LLC 0.15%
← Back to ALGERT GLOBAL LLC Holdings